Clinical Trials Logo

Clinical Trial Summary

SARS-CoV has caused severe epidemic respiratory disease in human populations. By July 2003, a total of 8,096 probable cases of SARS had been reported including 774 deaths in 27 countries, around one-third of which were health care workers (HCWs). Previous studies have been reported about long-term impacts of SARS infection, including lung function deficiency, steroid-induced osteonecrosis, reduced exercise capacity, and impairment in health-related quality of life (HRQoL). HCWs, especially nurses, have been reported to experience greater psychological distress, particularly increased levels of posttraumatic stress symptomatology (PTSS). But the very complex impacts of this fatal infection on HCWs have not been fully elucidated. It is thus important to follow these occupational patients to detect and manage multi-organ sequelae and functional impairment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03443102
Study type Observational
Source Peking University People's Hospital
Contact Yali Zheng, Dr
Phone +8615011451515
Email yali_zheng@126.com
Status Recruiting
Phase N/A
Start date January 25, 2018
Completion date December 1, 2018

See also
  Status Clinical Trial Phase
Completed NCT04527614 - Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection N/A
Completed NCT04453384 - Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia Phase 2
Not yet recruiting NCT04357613 - IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS. Phase 2
Enrolling by invitation NCT04363047 - Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19
Completed NCT04383535 - Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia N/A
Completed NCT04567927 - Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19
Recruiting NCT04381819 - Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19
Completed NCT00066209 - Investigating Severe Acute Respiratory Syndrome (SARS) N/A